Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.00384826827927434 -0.00164925783397477 -0.0186915887850467 -0.0186915887850467
Stock impact report

FDA accepts Valeant's application for psoriasis lotion Jemdel, action date October 5 [Seeking Alpha]

VALEANT PHARMACEUTICALS (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com
Company Research Source: Seeking Alpha
FDA accepts Valeant's application for psoriasis lotion Jemdel, action date October 5The FDAaccepts for review Valeant Pharmaceuticals (NYSE:VRX) unit Ortho Dermatologics' marketing application seeking approval for JEMDEL (halobetasol propionate 0.01%) lotion for the topical treatment of plaque psoriasis. The agency's action date is October 5.If approved, it will be the first topical steroid treatment for the disorder with dosing as long as eight weeks.Click to subscribe to real-time analytics on VRXNow read:Valeant: Perfect Time For An Equity Raise? » Show less Read more
Impact Snapshot
Event Time:
VRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VRX alerts
Opt-in for
VRX alerts

from News Quantified
Opt-in for
VRX alerts

from News Quantified